Zurück zu Peptide
Peptide

Topische PeptideStudienlage & Dosis

Argireline, Matrixyl, GHK-Cu — Anti-Aging-Kosmetik mit echter Evidenz.

Studienlage in Zahlen

Studien gesamt
130
Mit Abstract
47
Meta / Systematic / RCT
1
Häufig zitiert
23
Erscheinungsjahre
2008–2026

Topische Peptide im Kontext von Peptide

Dieses Thema ist Teil unserer Welt „Peptide". Dort findest du Methodik, Studienlage und Hebel mit dem größten Effekt — sowie die Reihenfolge, in der sich Hebel sinnvoll aufeinander aufbauen.

Zur Welt Peptide

Top-Studien zu Topische Peptide

Sortiert nach einflussreichen Zitationen und Erscheinungsjahr.

  1. Antimicrobial Peptides: An Emerging Category of Therapeutic Agents.

    Frontiers in cellular and infection microbiology2016200 einflussreiche Zitationen

    Antimicrobial peptides (AMPs), also known as host defense peptides, are short and generally positively charged peptides found in a wide variety of life forms from microorganisms to humans. Most AMPs have the ability to kill microbial…

  2. The expanding scope of antimicrobial peptide structures and their modes of action.

    Trends in biotechnology2011200 einflussreiche Zitationen

    Antimicrobial peptides (AMPs) are an integral part of the innate immune system that protect a host from invading pathogenic bacteria. To help overcome the problem of antimicrobial resistance, cationic AMPs are currently being considered as…

  3. Antimicrobial Peptides: Diversity, Mechanism of Action and Strategies to Improve the Activity and Biocompatibility In Vivo.

    Biomolecules2018200 einflussreiche Zitationen

    Antibiotic resistance is projected as one of the greatest threats to human health in the future and hence alternatives are being explored to combat resistance. Antimicrobial peptides (AMPs) have shown great promise, because use of AMPs…

  4. Development and Challenges of Antimicrobial Peptides for Therapeutic Applications.

    Antibiotics (Basel, Switzerland)2020200 einflussreiche Zitationen

    More than 3000 antimicrobial peptides (AMPs) have been discovered, seven of which have been approved by the U.S. Food and Drug Administration (FDA). Now commercialized, these seven peptides have mostly been utilized for topical…

  5. Antimicrobial peptides: Promising alternatives in the post feeding antibiotic era.

    Medicinal research reviews2019200 einflussreiche Zitationen

    Antimicrobial peptides (AMPs), critical components of the innate immune system, are widely distributed throughout the animal and plant kingdoms. They can protect against a broad array of infection‐causing agents, such as bacteria, fungi,…

  6. Antimicrobial Mechanisms and Clinical Application Prospects of Antimicrobial Peptides.

    Molecules (Basel, Switzerland)2022200 einflussreiche Zitationen

    Antimicrobial peptides are a type of small-molecule peptide that widely exist in nature and are components of the innate immunity of almost all living things. They play an important role in resisting foreign invading microorganisms.…

  7. Antimicrobial peptides: Opportunities and challenges in overcoming resistance.

    Microbiological research2024200 einflussreiche Zitationen

    Antibiotic resistance represents a global health threat, challenging the efficacy of traditional antimicrobial agents and necessitating innovative approaches to combat infectious diseases. Among these alternatives, antimicrobial peptides…

  8. Enhancing Antimicrobial Peptide Activity through Modifications of Charge, Hydrophobicity, and Structure.

    International journal of molecular sciences2024200 einflussreiche Zitationen

    Antimicrobial peptides (AMPs) are emerging as a promising alternative to traditional antibiotics due to their ability to disturb bacterial membranes and/or their intracellular processes, offering a potential solution to the growing problem…

  9. Antimicrobial peptides towards clinical application: Delivery and formulation.

    Advanced drug delivery reviews2021158 einflussreiche Zitationen

    Antimicrobial peptides hold promise to supplement small molecules antibiotics and combat the multidrug resistant microbes. There are however technical hurdles towards the clinical applications, largely due to the inherent limitations of…

  10. Antiviral peptides as promising therapeutic drugs.

    Cellular and molecular life sciences : CMLS2019129 einflussreiche Zitationen

    While scientific advances have led to large-scale production and widespread distribution of vaccines and antiviral drugs, viruses still remain a major cause of human diseases today. The ever-increasing reports of viral resistance and the…

Weitere Themen in Peptide

Peptide-Überblick

Peptide, BPC-157, TB-500, Sicherheit und Studienlage.

Verabreichung

Subkutan, intramuskulär, nasal, oral, topisch — Bioverfügbarkeit und Sicherheit.

Autoimmunitäts-Risiko

Immun-Modulation kann sowohl Toleranz fördern als auch entgleisen lassen.

BPC-157

Peptid für Geweberegeneration, Heilung und sportliche Erholung.

Cerebrolysin

Schweinehirn-Peptid-Mix, Schlaganfall-Studien, in DE unzugelassen.

CJC-1295

GHRH-Analog, Halbwertszeit-Varianten und Pulse-Patterns.

Dihexa

Angiotensin-Derivat, kognitive/Neuroplastizitäts-Hinweise im Tiermodell.

GHK-Cu

Kupfer-Peptid für Hautgesundheit, Anti-Aging und Wundheilung.

GHRP-2

GH-Releaser, älter, Appetit-Stimulation als Nebeneffekt.

GHRP-6

GH-Releaser mit starker Appetit-Komponente.

Rebound nach GLP-1

Gewichtszunahme nach Absetzen ohne Lifestyle-Anker.

GLP-1 Nebenwirkungen

Übelkeit, Magenentleerung, Muskelverlust, Pankreatitis-Risiko.

Hexarelin

GH-Releaser, Toleranz-Aufbau schnell, kardiale Hinweise.

IGF-1 LR3

Modifiziertes IGF-1 mit langer Halbwertszeit — Hypertrophie, Krebsrisiko-Debatte.

Immune Modulation

Automatisch via Trend Scout entdeckt. Supplements targeting inflammation and immune resilience remain a central research area.. PubMed: 11956 Ergebnisse.

Injektionssicherheit

Sterile Technik, BAC-Wasser, Hautdesinfektion — medizinisches Thema.

Ipamorelin

Selektiver GH-Releaser, Cortisol-Sparing und Stack-Kombinationen.

KPV

Alpha-MSH-Fragment — entzündungshemmend, Darm, Haut, frühe Forschung.

Liraglutid

Erste GLP-1-Generation für Diabetes/Adipositas — täglich, niedrigere Effektgröße.

LL-37

Antimikrobielles Peptid, Wundheilung, Immun-Modulation, frühe Forschung.

Verwandte Themen aus anderen Welten